Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis-Reference-Cited by-同舟云学术

Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis

Published:2021-10 Issue: Volume:59 Page:351-357
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Bianco Nadia^ORCID,Palazzo Antonella,Pagan Eleonora,Bagnardi Vincenzo,Milano Monica,De Maio Ana Paula,Colleoni Marco

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference18 articles.

1. Triple-negative breast cancer: recent treatment advances;Bergin;F1000Research,2019

2. Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial;von Minckwitz;Lancet Oncol,2014

3. Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis;Poggio 1;Ann Oncol,2018

4. Pembrolizumab for early triple-negative breast cancer;Schmid;N Engl J Med,2020

5. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooledanalysis;Cortazar;Lancet,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of non-coding RNAs mediated pyroptosis on cancer therapy: a review;Expert Review of Anticancer Therapy;2024-04-12

2. Adjuvant Capecitabine after Neoadjuvant Chemotherapy in Triple Negative Breast Cancer with Lymph Node Metastasis;Journal of the College of Physicians and Surgeons Pakistan;2023-09-01

3. A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate Cancer;Biomedicines;2023-07-25